Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.

<h4>Objective</h4>To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis disease (TB) incidence in sub-Saharan Africa.<h4>Methods</h4>We used a mathematical model to consider the effect of different assumptions about life expectan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peter J Dodd, Gwenan M Knight, Stephen D Lawn, Elizabeth L Corbett, Richard G White
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b6566b53549a498abc620cba2e3b1e86
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b6566b53549a498abc620cba2e3b1e86
record_format dspace
spelling oai:doaj.org-article:b6566b53549a498abc620cba2e3b1e862021-11-18T08:54:51ZPredicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.1932-620310.1371/journal.pone.0075466https://doaj.org/article/b6566b53549a498abc620cba2e3b1e862013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24069418/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis disease (TB) incidence in sub-Saharan Africa.<h4>Methods</h4>We used a mathematical model to consider the effect of different assumptions about life expectancy and TB risk during long-term ART under alternative scenarios for trends in population HIV incidence and ART coverage.<h4>Results</h4>All the scenarios we explored predicted that the widespread introduction of ART would initially reduce population-level TB incidence. However, many modelled scenarios projected a rebound in population-level TB incidence after around 20 years. This rebound was predicted to exceed the TB incidence present before ART scale-up if decreases in HIV incidence during the same period were not sufficiently rapid or if the protective effect of ART on TB was not sustained. Nevertheless, most scenarios predicted a reduction in the cumulative TB incidence when accompanied by a relative decline in HIV incidence of more than 10% each year.<h4>Conclusions</h4>Despite short-term benefits of ART scale-up on population TB incidence in sub-Saharan Africa, longer-term projections raise the possibility of a rebound in TB incidence. This highlights the importance of sustaining good adherence and immunologic response to ART and, crucially, the need for effective HIV preventive interventions, including early widespread implementation of ART.Peter J DoddGwenan M KnightStephen D LawnElizabeth L CorbettRichard G WhitePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e75466 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Peter J Dodd
Gwenan M Knight
Stephen D Lawn
Elizabeth L Corbett
Richard G White
Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
description <h4>Objective</h4>To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis disease (TB) incidence in sub-Saharan Africa.<h4>Methods</h4>We used a mathematical model to consider the effect of different assumptions about life expectancy and TB risk during long-term ART under alternative scenarios for trends in population HIV incidence and ART coverage.<h4>Results</h4>All the scenarios we explored predicted that the widespread introduction of ART would initially reduce population-level TB incidence. However, many modelled scenarios projected a rebound in population-level TB incidence after around 20 years. This rebound was predicted to exceed the TB incidence present before ART scale-up if decreases in HIV incidence during the same period were not sufficiently rapid or if the protective effect of ART on TB was not sustained. Nevertheless, most scenarios predicted a reduction in the cumulative TB incidence when accompanied by a relative decline in HIV incidence of more than 10% each year.<h4>Conclusions</h4>Despite short-term benefits of ART scale-up on population TB incidence in sub-Saharan Africa, longer-term projections raise the possibility of a rebound in TB incidence. This highlights the importance of sustaining good adherence and immunologic response to ART and, crucially, the need for effective HIV preventive interventions, including early widespread implementation of ART.
format article
author Peter J Dodd
Gwenan M Knight
Stephen D Lawn
Elizabeth L Corbett
Richard G White
author_facet Peter J Dodd
Gwenan M Knight
Stephen D Lawn
Elizabeth L Corbett
Richard G White
author_sort Peter J Dodd
title Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
title_short Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
title_full Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
title_fullStr Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
title_full_unstemmed Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
title_sort predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/b6566b53549a498abc620cba2e3b1e86
work_keys_str_mv AT peterjdodd predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis
AT gwenanmknight predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis
AT stephendlawn predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis
AT elizabethlcorbett predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis
AT richardgwhite predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis
_version_ 1718421161885302784